231 related articles for article (PubMed ID: 7951392)
21. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
22. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of protozoal and helminthic diseases of the gastrointestinal system in Israel].
El-On J; Karsenty E
Harefuah; 1984 Nov; 107(10):298-308. PubMed ID: 6530176
[No Abstract] [Full Text] [Related]
24. Tubulin as an antiprotozoal drug target.
Werbovetz KA
Mini Rev Med Chem; 2002 Dec; 2(6):519-29. PubMed ID: 12370037
[TBL] [Abstract][Full Text] [Related]
25. [New drugs for the treatment of human parasitic protozoa].
Dupouy-Camet J
Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
[TBL] [Abstract][Full Text] [Related]
26. New approaches for the identification of drug targets in protozoan parasites.
Müller J; Hemphill A
Int Rev Cell Mol Biol; 2013; 301():359-401. PubMed ID: 23317822
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic protozoa: an overview of in vitro cultivation and susceptibility to chemotherapeutic agents.
Fritsche TR
Clin Lab Med; 1989 Jun; 9(2):287-317. PubMed ID: 2659246
[TBL] [Abstract][Full Text] [Related]
28. Metabolic reconstruction and analysis for parasite genomes.
Pinney JW; Papp B; Hyland C; Wambua L; Westhead DR; McConkey GA
Trends Parasitol; 2007 Nov; 23(11):548-54. PubMed ID: 17950669
[TBL] [Abstract][Full Text] [Related]
29. Parasite vaccines: the new generation.
Crampton A; Vanniasinkam T
Infect Genet Evol; 2007 Sep; 7(5):664-73. PubMed ID: 17702669
[TBL] [Abstract][Full Text] [Related]
30. 8-Aminoquinolines: future role as antiprotozoal drugs.
Tekwani BL; Walker LA
Curr Opin Infect Dis; 2006 Dec; 19(6):623-31. PubMed ID: 17075340
[TBL] [Abstract][Full Text] [Related]
31. Toltrazuril effective against a broad spectrum of protozoan parasites.
Mehlhorn H; Schmahl G; Haberkorn A
Parasitol Res; 1988; 75(1):64-6. PubMed ID: 3144713
[No Abstract] [Full Text] [Related]
32. Content, synthesis, and function of polyamines in trypanosomatids: relationship to chemotherapy.
Bacchi CJ
J Protozool; 1981 Feb; 28(1):20-7. PubMed ID: 6788943
[No Abstract] [Full Text] [Related]
33. Understanding drug resistance in human intestinal protozoa.
El-Taweel HA
Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of human diseases caused by protozoal parasites. II].
Fossati C
Clin Ter; 1978 Nov; 87(3):273-99. PubMed ID: 753575
[No Abstract] [Full Text] [Related]
35. The efficacy of some drugs with known antiprotozoal activity against Histomonas meleagridis in chickens.
Hu J; McDougald LR
Vet Parasitol; 2004 May; 121(3-4):233-8. PubMed ID: 15135862
[TBL] [Abstract][Full Text] [Related]
36. Antiprotozoan activity of nitroimidazoles.
De Carneri I
Arzneimittelforschung; 1969 Mar; 19(3):382-6. PubMed ID: 4889732
[No Abstract] [Full Text] [Related]
37. Protein kinases as targets for anti-parasitic chemotherapy.
Doerig C
Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
[TBL] [Abstract][Full Text] [Related]
38. Editorial of the special issue "Parasitology in Mexico".
Correa D; Talamás-Rohana P; Flisser A
Infect Genet Evol; 2009 Dec; 9(6):1021-2. PubMed ID: 19833231
[No Abstract] [Full Text] [Related]
39. Drug targets for the treatment of protozoan parasitic diseases.
Guddat L
Curr Top Med Chem; 2011; 11(16):2010-1. PubMed ID: 21619516
[No Abstract] [Full Text] [Related]
40. [Basic trends and the prospects for creating new synthetic chemotherapeutic preparations].
Pershin GN
Antibiotiki; 1980 Oct; 25(10):723-9. PubMed ID: 7425591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
